Out of the 15 subjects, methylphenidate raised brain metabolism in six, lowered it in two, and had no effect in seven. However, it universally increased metabolism in the cerebellum. The drug significantly boosted relative metabolism in the cerebellum while decreasing it in the basal ganglia. Changes in cerebellum, frontal, and temporal cortex metabolism were strongly linked to D2 receptor availability. Those with higher D2 receptors saw increased frontal and temporal metabolism, while those with lower D2 receptors saw decreases.